Perbedaan UBC Medical Indonesia Tbk. dan Suryamas Dutamakmur Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb), sedangkan Suryamas Dutamakmur Tbk. diperdagangkan di Rp550 (kapitalisasi pasar 2,62 T, volume 24 jam 50,2 rb). Perbedaan utamanya: Suryamas Dutamakmur Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (635,5 rb vs 50,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | SMDM | |
|---|---|---|
Kapitalisasi Pasar | 691,25 M | 2,62 T |
Volume | 635,5 rb | 50,2 rb |
Lot | 6,36 rb | 502 |
Perputaran | 110,15 jt | 26,74 jt |
Harga Rata-rata | 173,33 | 532,67 |
Nilai Transaksi | 110,15 jt | 26,74 jt |
Harga Ekuilibrium Indikatif | 174 | 550 |
Volume Ekuilibrium Indikatif | 50 | 2 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Suryamas Dutamakmur Tbk (the Company) was established based on notarial Deed No. 322, dated September 21, 1989 of Benny Kristianto, S.H., notary in Jakarta. PT. Suryamas Dutamakmur has a specific aim to participate in meeting the growing demand for quality residential development in the Greater Jakarta area.
Selengkapnya di halaman SMDM →